Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial.

Journal:

Annals of Surgery

Published:

2025-08-13

DOI:

10.1097/sla.0000000000006910

Affiliations:

18

Authors:

30

Go to article

Institutions	Authors	Share
Amsterdam UMC, Netherlands	8.000000	0.27
Erasmus University Medical Center (Erasmus MC), Netherlands	7.000000	0.23
Isala Clinics, Netherlands	2.000000	0.07
Maasstad Hospital, Netherlands	2.000000	0.07
Leiden University Medical Center (LUMC), Netherlands	2.000000	0.07
Regional Academic Cancer Center Utrecht, Netherlands	1.000000	0.03
Catharina Hospital, Netherlands	1.000000	0.03
Amphia Hospital, Netherlands	1.000000	0.03
Frisius MC, Netherlands	1.000000	0.03
Medisch Spectrum Twente, Netherlands	1.000000	0.03
Onze Lieve Vrouwen Gasthuis (OLVG), Netherlands	1.000000	0.03
Radboud University Medical Centre (Radboudumc), RU, Netherlands	1.000000	0.03
Jeroen Bosch Ziekenhuis (JBZ), Netherlands	1.000000	0.03
Maastricht University Medical Center+ (Maastricht UMC+), Netherlands	1.000000	0.03

Interested in Oncology and Carcinogenesis?